Syndrome News and Research

RSS

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

New research in nursing home residents found that a third dose of the Pfizer-BioNTech COVID-19 vaccine was effective for at least three months in protecting against the Delta and Omicron variant. While two doses of an mRNA COVID-19 vaccine showed poor neutralization to Omicron than Delta, a booster shot increased neutralizing antibody responses.

22 Feb 2022

Pre-existing B-cell immunity against SARS-CoV-2 not detected in pre-pandemic samples

A recent study investigates samples solated from unexposed individuals pre-pandemic to determine the presence of pre-existing SARS-CoV-2 B-cell immunity.

22 Feb 2022

Role of SARS-CoV-2 seroprevalence studies in disease surveillance

A new study aimed to determine the timelessness of SARS-CoV-2 seroprevalence studies in providing information that is useful in public health surveillance.

22 Feb 2022

CD91 receptor promotes SARS-CoV-2 infection

researchers find that LRP1/CD91 is a leading molecule in virus-host cell interactions that causes infection by many RNA viruses.

22 Feb 2022

Poor sleep increases severity of viral respiratory infections including COVID-19

A new study explores the risk of respiratory infection with poor sleep in the context of the ongoing COVID-19 pandemic.

22 Feb 2022

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

Researchers explore the potential of mosaic receptor-binding domain nanoparticles in protective immunity against SARS-CoV-2

22 Feb 2022

Breath tests can help detect traces of SARS-CoV-2 virus

Traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in microscopically small fluid droplets exhaled during a very short time span.

22 Feb 2022

Cellular automata imaging-based classification of SARS-CoV-2 variants

A new preprint classified and grouped SARS-CoV-2 variants based on their cellular automata imaging images and Hamming distances, to determine viral evolutions.

22 Feb 2022

Study explores the decline in viral load and immune response in COVID-19 patients

Researchers described the changes in viral ribonucleic acid the decline in viral load, and the immune response of SARS-CoV-2-infected patients, in a new preprint study.

22 Feb 2022

SARS-CoV-2 Omicron variant rapidly takes over Delta viral strain in Norwegian households

Researchers compared the secondary attack rates SARS-CoV-2 Omicron and Delta variants of concern in Norwegian households.

22 Feb 2022

Assessing the transmissibility of SARS-CoV-2 variants of concern

A new study investigated and compared the transmissibility of severe acute respiratory syndrome coronavirus-2 variants of concern.

22 Feb 2022

Severity of SARS-CoV-2 infections with Omicron BA.2 variant relative to the BA.1 variant in South Africa

Researchers estimated the clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage relative to the BA.1 variant in South Africa.

22 Feb 2022

REGEN-COV antibody combination to prevent COVID-19 severity

A new study assessed the effectiveness of REGEN-COV, a combination of casirivimab and imdevimab monoclonal antibodies, in the prevention of COVID-19 disease severity.

22 Feb 2022

Study provides a potent biparatopic antibody against all SARS-CoV-2 variants of concern

Researchers demonstrated the potent neutralization of SARS-CoV-2 VOCs, including Omicron by the biparatopic human heavy chain variable domain.

22 Feb 2022

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Researchers conducted a prospective cohort study to determine the prevalence of chemosensory dysfunction in mild to moderate COVID-19 patients in Italy.

22 Feb 2022

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Researchers evaluated the incidences of SARS-CoV-2 reinfections, hospitalizations, and death among the previously infected population of the Abruzzo region in Italy.

22 Feb 2022

Studies continue to prove ivermectin for COVID-19 treatment ineffectual

Researchers from hospitals around Malaysia have been looking into the efficacy of the controversial drug ivermectin as a possible COVID-19 treatment.

22 Feb 2022

Widely utilized SARS-CoV-2 rapid antigen detection tests continue to perform as expected despite Omicron mutations

A recent study evaluated the performance of three at-home COVID-19 rapid antigen tests commonly used in the US against the SARS-CoV-2 Omicron variant.

22 Feb 2022

Lung microbiome alterations and secondary-infections in lethal COVID-19

Researchers examined how an interplay of host and microbial factors weakened immunity leading to secondary infections in COVID-19-infected individuals.

22 Feb 2022

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

Researchers attempted to delineate the duration and stability of anti-SARS-CoV-2 antibodies in patients who had recovered from the COVID-19 infection.

22 Feb 2022